$CCCC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in C4 Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in C4 Therapeutics, Inc.. Get notifications about new insider transactions in C4 Therapeutics, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 21 2021 | CCCC | C4 Therapeutics, I ... | Salter Malcolm | Director | Sell | S | 37.19 | 755 | 28,078 | 14,843 | 15.6 K to 14.8 K (-4.84 %) |
| Jun 21 2021 | CCCC | C4 Therapeutics, I ... | White Lauren | Chief Financial Off ... | Option Exercise | A | 38.49 | 136,000 | 5,234,640 | 136,000 | |
| Apr 14 2021 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Option Exercise | M | 4.98 | 444 | 2,211 | 4,002 | |
| Apr 14 2021 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Option Exercise | M | 2.11 | 267 | 563 | 2,940 | |
| Apr 14 2021 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Buy | M | 4.98 | 444 | 2,211 | 85,146 | 84.7 K to 85.1 K (+0.52 %) |
| Apr 14 2021 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Buy | M | 2.11 | 267 | 563 | 84,702 | 84.4 K to 84.7 K (+0.32 %) |
| Apr 14 2021 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Gift | G | 0.00 | 2,278 | 0 | 47,316 | 45 K to 47.3 K (+5.06 %) |
| Apr 14 2021 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Gift | G | 0.00 | 2,278 | 0 | 84,435 | 82.2 K to 84.4 K (+2.77 %) |
| Apr 06 2021 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Grant | A | 37.51 | 233 | 8,740 | 82,157 | 81.9 K to 82.2 K (+0.28 %) |
| Apr 06 2021 | CCCC | C4 Therapeutics, I ... | Crystal Adam | Chief Medical Offic ... | Option Exercise | M | 6.50 | 15,000 | 97,500 | 157,292 | |
| Apr 06 2021 | CCCC | C4 Therapeutics, I ... | Crystal Adam | Chief Medical Offic ... | Sell | S | 38.00 | 10,879 | 413,407 | 0 | 10.9 K to 0 (-100.00 %) |
| Apr 06 2021 | CCCC | C4 Therapeutics, I ... | Crystal Adam | Chief Medical Offic ... | Sell | S | 37.16 | 4,121 | 153,129 | 10,879 | 15 K to 10.9 K (-27.47 %) |
| Apr 06 2021 | CCCC | C4 Therapeutics, I ... | Crystal Adam | Chief Medical Offic ... | Buy | M | 6.50 | 15,000 | 97,500 | 15,000 | 0 to 15 K |
| Apr 06 2021 | CCCC | C4 Therapeutics, I ... | Salter Malcolm | Director | Grant | A | 37.51 | 359 | 13,466 | 16,353 | 16 K to 16.4 K (+2.24 %) |
| Apr 06 2021 | CCCC | C4 Therapeutics, I ... | COHEN ALAIN J | Director | Grant | A | 37.51 | 266 | 9,978 | 266 | 0 to 266 |
| Apr 06 2021 | CCCC | C4 Therapeutics, I ... | COHEN MARC A | Director | Grant | A | 37.51 | 553 | 20,743 | 6,119 | 5.6 K to 6.1 K (+9.94 %) |
| Mar 16 2021 | CCCC | C4 Therapeutics, I ... | Dubin Glenn | Director | Option Exercise | A | 44.64 | 41,200 | 1,839,168 | 41,200 | |
| Feb 16 2021 | CCCC | C4 Therapeutics, I ... | Wahlberg Laura Jean | VP of Finance Corp ... | Option Exercise | A | 45.54 | 23,100 | 1,051,974 | 23,100 | |
| Feb 16 2021 | CCCC | C4 Therapeutics, I ... | Fisher Stewart | Chief Scientific Of ... | Option Exercise | A | 45.54 | 94,950 | 4,324,023 | 94,950 | |
| Feb 16 2021 | CCCC | C4 Therapeutics, I ... | Crystal Adam | Chief Medical Offic ... | Option Exercise | A | 45.54 | 87,850 | 4,000,689 | 87,850 | |
| Feb 04 2021 | CCCC | C4 Therapeutics, I ... | Fisher Stewart | Chief Scientific Of ... | Option Exercise | M | 3.71 | 5,929 | 21,997 | 55,514 | |
| Feb 04 2021 | CCCC | C4 Therapeutics, I ... | Fisher Stewart | Chief Scientific Of ... | Option Exercise | M | 2.11 | 2,371 | 5,003 | 2,371 | |
| Feb 04 2021 | CCCC | C4 Therapeutics, I ... | Fisher Stewart | Chief Scientific Of ... | Option Exercise | M | 3.71 | 9,701 | 35,991 | 61,443 | |
| Feb 04 2021 | CCCC | C4 Therapeutics, I ... | Fisher Stewart | Chief Scientific Of ... | Option Exercise | M | 2.11 | 4,743 | 10,008 | 4,742 | |
| Feb 04 2021 | CCCC | C4 Therapeutics, I ... | Fisher Stewart | Chief Scientific Of ... | Buy | M | 3.71 | 5,929 | 21,997 | 108,116 | 102.2 K to 108.1 K (+5.80 %) |
| Feb 04 2021 | CCCC | C4 Therapeutics, I ... | Fisher Stewart | Chief Scientific Of ... | Buy | M | 2.11 | 2,371 | 5,003 | 102,187 | 99.8 K to 102.2 K (+2.38 %) |
| Feb 04 2021 | CCCC | C4 Therapeutics, I ... | Fisher Stewart | Chief Scientific Of ... | Buy | M | 3.71 | 9,701 | 35,991 | 99,816 | 90.1 K to 99.8 K (+10.77 %) |
| Feb 04 2021 | CCCC | C4 Therapeutics, I ... | Fisher Stewart | Chief Scientific Of ... | Buy | M | 2.11 | 4,743 | 10,008 | 90,115 | 85.4 K to 90.1 K (+5.56 %) |
| Jan 26 2021 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Option Exercise | M | 4.98 | 889 | 4,427 | 4,446 | |
| Jan 26 2021 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Option Exercise | M | 2.11 | 121 | 255 | 0 | |
| Jan 26 2021 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Option Exercise | M | 2.11 | 538 | 1,135 | 3,207 | |
| Jan 26 2021 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Buy | M | 4.98 | 889 | 4,427 | 81,924 | 81 K to 81.9 K (+1.10 %) |
| Jan 26 2021 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Buy | M | 2.11 | 121 | 255 | 81,035 | 80.9 K to 81 K (+0.15 %) |
| Jan 26 2021 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Buy | M | 2.11 | 538 | 1,135 | 80,914 | 80.4 K to 80.9 K (+0.67 %) |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | MCKEE WILLIAM | Chief Financial Off ... | Buy | P | 19.00 | 5,263 | 99,997 | 5,263 | 0 to 5.3 K |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | MCKEE WILLIAM | Chief Financial Off ... | Buy | P | 19.00 | 5,263 | 99,997 | 5,263 | 0 to 5.3 K |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN MARC A | Director | Option Exercise | C | 0.00 | 20,952,403 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN MARC A | Director | Option Exercise | C | 0.00 | 12,500,000 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN MARC A | Director | Option Exercise | C | 0.00 | 20,952,403 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN MARC A | Director | Option Exercise | C | 0.00 | 2,000,000 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN MARC A | Director | Option Exercise | C | 0.00 | 12,500,000 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN MARC A | Director | Buy | P | 19.00 | 5,030 | 95,570 | 5,030 | 0 to 5 K |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN MARC A | Director | Option Exercise | C | 0.00 | 2,000,000 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN MARC A | Director | Buy | C | 0.00 | 2,484,425 | 0 | 2,484,425 | 0 to 2.5 M |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN MARC A | Director | Buy | P | 19.00 | 5,030 | 95,570 | 5,030 | 0 to 5 K |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN MARC A | Director | Buy | C | 0.00 | 1,482,183 | 0 | 1,852,207 | 370 K to 1.9 M (+400.56 %) |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN MARC A | Director | Buy | C | 0.00 | 2,484,425 | 0 | 2,484,425 | 0 to 2.5 M |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN MARC A | Director | Buy | C | 0.00 | 237,149 | 0 | 370,024 | 132.9 K to 370 K (+178.48 %) |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN MARC A | Director | Buy | C | 0.00 | 1,482,183 | 0 | 1,852,207 | 370 K to 1.9 M (+400.56 %) |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Option Exercise | C | 0.00 | 142,857 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN MARC A | Director | Buy | C | 0.00 | 237,149 | 0 | 370,024 | 132.9 K to 370 K (+178.48 %) |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Option Exercise | C | 0.00 | 142,857 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Option Exercise | C | 0.00 | 142,857 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Option Exercise | C | 0.00 | 347,840 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Option Exercise | C | 0.00 | 142,857 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Option Exercise | C | 0.00 | 347,840 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Option Exercise | C | 0.00 | 347,840 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Option Exercise | C | 0.00 | 152,160 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Option Exercise | C | 0.00 | 347,840 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Option Exercise | C | 0.00 | 152,160 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Option Exercise | C | 0.00 | 152,160 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Buy | C | 0.00 | 16,939 | 0 | 16,939 | 0 to 16.9 K |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Option Exercise | C | 0.00 | 152,160 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Buy | C | 0.00 | 16,939 | 0 | 16,939 | 0 to 16.9 K |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Buy | C | 0.00 | 16,939 | 0 | 16,939 | 0 to 16.9 K |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Buy | C | 0.00 | 41,244 | 0 | 63,543 | 22.3 K to 63.5 K (+184.96 %) |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Buy | C | 0.00 | 16,939 | 0 | 16,939 | 0 to 16.9 K |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Buy | C | 0.00 | 41,244 | 0 | 63,543 | 22.3 K to 63.5 K (+184.96 %) |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Buy | C | 0.00 | 41,244 | 0 | 63,543 | 22.3 K to 63.5 K (+184.96 %) |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Buy | C | 0.00 | 18,040 | 0 | 45,038 | 27 K to 45 K (+66.82 %) |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Buy | C | 0.00 | 41,244 | 0 | 63,543 | 22.3 K to 63.5 K (+184.96 %) |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Buy | C | 0.00 | 18,040 | 0 | 80,376 | 62.3 K to 80.4 K (+28.94 %) |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Buy | C | 0.00 | 18,040 | 0 | 45,038 | 27 K to 45 K (+66.82 %) |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | DOWNEY BRUCE | Director | Option Exercise | C | 0.00 | 2,128,571 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Buy | C | 0.00 | 18,040 | 0 | 80,376 | 62.3 K to 80.4 K (+28.94 %) |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | DOWNEY BRUCE | Director | Option Exercise | C | 0.00 | 2,000,000 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | DOWNEY BRUCE | Director | Option Exercise | C | 0.00 | 2,128,571 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | DOWNEY BRUCE | Director | Buy | C | 0.00 | 252,394 | 0 | 489,542 | 237.1 K to 489.5 K (+106.43 %) |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | DOWNEY BRUCE | Director | Option Exercise | C | 0.00 | 2,000,000 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | DOWNEY BRUCE | Director | Buy | C | 0.00 | 237,148 | 0 | 237,148 | 0 to 237.1 K |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | DOWNEY BRUCE | Director | Buy | C | 0.00 | 252,394 | 0 | 489,542 | 237.1 K to 489.5 K (+106.43 %) |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | DOWNEY BRUCE | Director | Buy | C | 0.00 | 237,148 | 0 | 237,148 | 0 to 237.1 K |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Salter Malcolm | Director | Option Exercise | C | 0.00 | 23,809 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Salter Malcolm | Director | Option Exercise | C | 0.00 | 23,809 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Salter Malcolm | Director | Option Exercise | C | 0.00 | 100,000 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Salter Malcolm | Director | Option Exercise | C | 0.00 | 100,000 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Salter Malcolm | Director | Buy | P | 19.00 | 1,315 | 24,985 | 15,994 | 14.7 K to 16 K (+8.96 %) |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Salter Malcolm | Director | Buy | P | 19.00 | 1,315 | 24,985 | 15,994 | 14.7 K to 16 K (+8.96 %) |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Salter Malcolm | Director | Buy | C | 0.00 | 2,823 | 0 | 14,679 | 11.9 K to 14.7 K (+23.81 %) |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Salter Malcolm | Director | Buy | C | 0.00 | 2,823 | 0 | 14,679 | 11.9 K to 14.7 K (+23.81 %) |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Salter Malcolm | Director | Buy | C | 0.00 | 11,856 | 0 | 11,856 | 0 to 11.9 K |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Salter Malcolm | Director | Buy | C | 0.00 | 11,856 | 0 | 11,856 | 0 to 11.9 K |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN ALAIN J | Director | Option Exercise | C | 0.00 | 20,952,403 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN ALAIN J | Director | Option Exercise | C | 0.00 | 20,952,403 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN ALAIN J | Director | Option Exercise | C | 0.00 | 12,500,000 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN ALAIN J | Director | Option Exercise | C | 0.00 | 12,500,000 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN ALAIN J | Director | Option Exercise | C | 0.00 | 2,000,000 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN ALAIN J | Director | Option Exercise | C | 0.00 | 2,000,000 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN ALAIN J | Director | Buy | C | 0.00 | 2,484,425 | 0 | 2,484,425 | 0 to 2.5 M |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN ALAIN J | Director | Buy | C | 0.00 | 2,484,425 | 0 | 2,484,425 | 0 to 2.5 M |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN ALAIN J | Director | Buy | C | 0.00 | 1,482,183 | 0 | 1,719,332 | 237.1 K to 1.7 M (+625.00 %) |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN ALAIN J | Director | Buy | C | 0.00 | 1,482,183 | 0 | 1,719,332 | 237.1 K to 1.7 M (+625.00 %) |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN ALAIN J | Director | Buy | C | 0.00 | 237,149 | 0 | 237,149 | 0 to 237.1 K |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | COHEN ALAIN J | Director | Buy | C | 0.00 | 237,149 | 0 | 237,149 | 0 to 237.1 K |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Prokupets Elena | Director | Option Exercise | C | 0.00 | 5,000,000 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Prokupets Elena | Director | Option Exercise | C | 0.00 | 5,000,000 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Prokupets Elena | Director | Option Exercise | C | 0.00 | 1,000,000 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Prokupets Elena | Director | Option Exercise | C | 0.00 | 1,000,000 | 0 | 0 | |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Prokupets Elena | Director | Buy | C | 0.00 | 592,873 | 0 | 592,873 | 0 to 592.9 K |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Prokupets Elena | Director | Buy | C | 0.00 | 592,873 | 0 | 592,873 | 0 to 592.9 K |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Prokupets Elena | Director | Buy | C | 0.00 | 118,574 | 0 | 118,574 | 0 to 118.6 K |
| Oct 06 2020 | CCCC | C4 Therapeutics, I ... | Prokupets Elena | Director | Buy | C | 0.00 | 118,574 | 0 | 118,574 | 0 to 118.6 K |
| Oct 05 2020 | CCCC | C4 Therapeutics, I ... | Salter Malcolm | Director | Option Exercise | A | 19.00 | 17,786 | 337,934 | 17,786 | |
| Oct 05 2020 | CCCC | C4 Therapeutics, I ... | Hirsch Andrew | See Remarks | Option Exercise | A | 19.00 | 1,691,672 | 32,141,768 | 1,691,672 | |
| Oct 05 2020 | CCCC | C4 Therapeutics, I ... | COHEN MARC A | Director | Option Exercise | A | 19.00 | 17,786 | 337,934 | 17,786 | |
| Oct 05 2020 | CCCC | C4 Therapeutics, I ... | COHEN MARC A | Director | Option Exercise | A | 19.00 | 725,002 | 13,775,038 | 725,002 | |
| Oct 05 2020 | CCCC | C4 Therapeutics, I ... | Prokupets Elena | Director | Option Exercise | A | 19.00 | 17,786 | 337,934 | 17,786 | |
| Oct 05 2020 | CCCC | C4 Therapeutics, I ... | DOWNEY BRUCE | Director | Option Exercise | A | 19.00 | 17,786 | 337,934 | 17,786 | |
| Oct 05 2020 | CCCC | C4 Therapeutics, I ... | COHEN ALAIN J | Director | Option Exercise | A | 19.00 | 17,786 | 337,934 | 17,786 | |
| Oct 05 2020 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Option Exercise | A | 19.00 | 17,786 | 337,934 | 17,786 |
Page: 1